Immuno-Oncology News

September 20, 2019September 20, 2019

FDA Fast-tracks Magrolimab for Treatment of Myelodysplastic Syndrome, Acute Myeloid Leukemia

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Magrolimab, an experimental antibody developed by Forty Seven, ... Read more

September 18, 2019September 18, 2019

First-line Imfinzi-Chemo Therapy Extends Survival of Patients with Aggressive Lung Cancer, Phase 3 Trial Shows

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Adding the immune checkpoint inhibitor Imfinzi (durvalumab) to ... Read more

September 17, 2019September 17, 2019

Keytruda and Inlyta Combo Approved in Europe for Untreated Advanced Kidney Cancer

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The European Commission has approved a combination of ... Read more

September 13, 2019September 13, 2019

Nanotechnology May Help Get Immunotherapy Into the Brain, Mouse Study Says

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Immunotherapies have shown little efficacy in brain cancers ... Read more

September 11, 2019September 11, 2019

FDA Grants Orphan Drug Status to BioXcel’s BXCL701 as Potential AML Treatment

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has ... Read more

September 10, 2019September 10, 2019

Health Canada and European Commission OK Tecentriq-Chemo Combo for Aggressive Lung Cancer

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Health Canada and the European Commission have approved Tecentriq ... Read more

September 4, 2019September 4, 2019

Trial of Targeted Radiation Therapy, CLR 131, in Children with Advanced Cancers Moving to Higher Dose

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Cellectar Biosciences announced that a second and higher ... Read more

September 3, 2019September 3, 2019

Imfinzi-Tremelimumab Combo Fails to Prolong Overall Survival in Metastatic NSCLC, Phase 3 Trial Shows

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site A combination of tremelimumab plus Imfinzi (durvalumab) is ... Read more

August 30, 2019August 30, 2019

Pexa-Vec Combo Unlikely to Benefit Advanced Liver Cancer Patients in Phase 3 Trial, Monitoring Group Says

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Adding the cancer vaccine Pexa-Vec to Nexavar (sorafenib), ... Read more

August 28, 2019August 28, 2019

$102.2M Pelotonia Gift to Help Establish Immuno-Oncology Institute at OSU

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site A $102.2 million Pelotonia donation will help establish ... Read more